4.7 Article

Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study

Jacob Christian Lindegaard et al.

Summary: The study validated a simple scoring system (TS) in a multicenter setting, which has the capability to predict local control and survival in locally advanced cervical cancer treated with chemoradiation and MRI-guided brachytherapy. TS regression during initial chemoradiation was found to be significant in predicting outcomes related to BT technique, dose-volume histogram parameters, local control, survival, and morbidity.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Oncology

Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples

Karoline Andersen et al.

Summary: This study demonstrates the use of a targeted HPV next generation sequencing (NGS) panel for cervical cancer screening. The targeted panel shows similar sensitivity and specificity to commercial HPV assays, but also provides additional advantages such as specific detection of all relevant HPV types and identification of viral integration and variants.

CANCERS (2022)

Article Cell Biology

The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients

Sara Bonlokke et al.

Summary: Circulating cell-free HPV DNA (ccfHPV DNA) can serve as a marker for cervical cancer. This study used digital droplet PCR (ddPCR) to detect and quantify ccfHPV DNA in plasma from patients with HPV16- or HPV18-associated cervical cancer. The results showed that ccfHPV DNA may not be useful for early detection of cervical cancer, but it can be a promising tool for establishing tumor burden and monitoring the disease in advanced stage cervical cancer patients.
Article Oncology

CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)

David Cibula et al.

Summary: This study aims to evaluate whether adjuvant (chemo)radiation after radical surgery provides a survival benefit in patients with intermediate-risk cervical cancer. Patients will be randomized into two groups to compare the disease-free survival rates between the two treatment strategies.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Article Medicine, Research & Experimental

Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker

Phetploy Rungkamoltip et al.

Summary: The study suggests that HPV E7 cfDNA could serve as a specific biomarker for cervical cancer detection with potential for monitoring. Both isothermal detection and ddPCR showed high sensitivity and specificity for HPV16/18 E7 cfDNA, while the RPA-LF method offers an affordable, rapid, and ultrasensitive tool for detecting HPV in resource-limited settings.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Article Pathology

Targeted next generation sequencing panel for HPV genotyping in cervical cancer

J. Lippert et al.

Summary: The study demonstrates that targeted NGS is effective in detecting and genotyping HPV in both FFPE biopsies and plasma samples. This method provides early diagnosis and prognosis for cervical cancer progression, enhancing recovery and survival potential for patients.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2021)

Article Oncology

PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers

E. E. Dumbrava et al.

Summary: Analysis of PIK3CA mutations in circulating tumor DNA is consistent with testing of archival tumor tissue. Low quantity of PIK3CA-mutant ctDNA is associated with longer survival, while a decrease in PIK3CA-mutant ctDNA during therapy is associated with longer time to treatment failure.

ESMO OPEN (2021)

Article Oncology

Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

Kimberly Levinson et al.

Summary: This study evaluated and compared risk factors for recurrence in squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the cervix, developing histology-specific nomograms to estimate the risk of recurrence. Results showed differences in recurrence risk factors between SCC and AC, emphasizing the importance of tailoring adjuvant treatment strategies based on histology-specific characteristics for cervical cancer patients.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

L. Cabel et al.

Summary: The study designed HPV droplet digital PCR (ddPCR) assays for blood detection and monitored blood HPV circulating tumor DNA (HPV ctDNA) levels in patients with LACC undergoing CRT. Results showed successful detection of HPV ctDNA in 69% of patients before CRT, with a correlation between HPV-ctDNA levels and HPV copy number in tumors. Detection of HPV-ctDNA before CRT was associated with tumor stage and lymph node status, while positive detection during follow-up was linked to lower disease-free and overall survival rates.

ESMO OPEN (2021)

Article Multidisciplinary Sciences

Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR

Miguel Alcaide et al.

SCIENTIFIC REPORTS (2020)

Review Oncology

Life and death of circulating cell-free DNA

Anatoli Kustanovich et al.

CANCER BIOLOGY & THERAPY (2019)

Article Virology

Liquid biopsy of HPV DNA in cervical cancer

Tak Hong Cheung et al.

JOURNAL OF CLINICAL VIROLOGY (2019)

Article Medicine, Research & Experimental

The Presence of Human Papillomavirus DNA Integration is Associated with Poor Clinical Results in Patients with Third-Stage Cervical Cancer

V. I. Kiseleva et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2019)

Editorial Material Obstetrics & Gynecology

Revised FIGO staging for carcinoma of the cervix uteri

Neerja Bhatla et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2019)

Review Medicine, General & Internal

Cervical cancer

Paul A. Cohen et al.

LANCET (2019)

Editorial Material Genetics & Heredity

Advances in liquid biopsy approaches for early detection and monitoring of cancer

Anna Babayan et al.

GENOME MEDICINE (2018)

Article Genetics & Heredity

Mechanistic signatures of HPV insertions in cervical carcinomas

Allyson Holmes et al.

NPJ GENOMIC MEDICINE (2016)

Article Oncology

Liquid Biopsies: Genotyping Circulating Tumor DNA

Luis A. Diaz et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Meeting Abstract Oncology

DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES

Chetan Bettegowda et al.

NEURO-ONCOLOGY (2014)

Article Infectious Diseases

Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia

A. Gradissimo Oliveira et al.

CLINICAL MICROBIOLOGY AND INFECTION (2013)

Article Multidisciplinary Sciences

The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line

Andrew Adey et al.

NATURE (2013)

Review Oncology

Cell-free nucleic acids as biomarkers in cancer patients

Heidi Schwarzenbach et al.

NATURE REVIEWS CANCER (2011)

Article Microbiology

Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer

Hugo Arias-Pulido et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2006)

Article Multidisciplinary Sciences

Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response

MR Pett et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)